OK Biotech Co., Ltd. (TPE:4155)

Market Cap	1.84B -24.5%
Revenue (ttm)	1.56B -6.8%
Net Income	82.45M -12.3%
EPS	0.57 -11.5%
Shares Out	141.12M
PE Ratio	22.92
Forward PE	n/a
Dividend	0.30 (2.30%)
Ex-Dividend Date	Jul 4, 2025

Volume	251,210
Average Volume	256,628
Open	13.20
Previous Close	13.20
Day's Range	13.00 - 13.25
52-Week Range	12.85 - 18.15
Beta	0.18
RSI	43.16
Earnings Date	May 12, 2026

About OK Biotech

OK Biotech Co., Ltd., together with its subsidiaries, engages in the research, development, manufacture, and sale of blood glucose monitoring systems and homecare healthcare devices in Taiwan, the rest of Asia, America, Africa, and Europe. The company offers nebulizers, blood glucose meters, glucometers, blood sugar meters, and blood glucose test strips. It also provides OTC hearing aids, multi-frequency therapy devices, and factory setup solutions, as well as professional OEM/ODM customized services. The company sells its products under the OK...

• Industry: Medical Devices
• Sector: Healthcare
• Founded: 2004
• Country: Taiwan
• Stock Exchange: Taiwan Stock Exchange
• Ticker Symbol: 4155

Financial Performance

In 2025, OK Biotech's revenue was 1.56 billion, a decrease of -6.81% compared to the previous year's 1.67 billion. Earnings were 82.45 million, a decrease of -12.26%.